Interaction of metformin with the vitamin K antagonist phenprocoumon

被引：0
|
作者：
Wijnen, J. [1 ]
Van de Riet, I [1 ]
Lijfering, W. M. [1 ]
Van der Meer, F. [1 ]
机构：
[1] LUMC, Leiden, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：823 / 824
页数：2
相关论文
共 50 条
  • [21] Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation
    Kreutz, Reinhold
    Kloss, Sebastian
    Enders, Dirk
    Abdelgawwad, Khaled
    Haeckl, Dennis
    Schmedt, Niklas
    Bonnemeier, Hendrik
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 404
  • [22] Ischaemic stroke after exposure to aflibercept: interaction with vitamin K antagonist and/or direct pharmacodynamic effect?
    Thorel, J.
    Civade, E.
    Quintyn, J. C.
    Cestac, P.
    Montastruc, J. -L.
    Bagheri, H.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (04) : 477 - 479
  • [23] Drug-drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants
    Mathy, Francois-Xavier
    Dohin, Elisabeth
    Bonfitto, Francois
    Pelgrims, Barbara
    EUROPEAN HEART JOURNAL, 2019, 40 (19) : 1571 - 1571
  • [24] Relationship Amongst Vitamin K Status, Vitamin K Antagonist Use and Osteoarthritis: A Review
    Kok-Yong Chin
    Kok-Lun Pang
    Sok Kuan Wong
    Deborah Chia Hsin Chew
    Haji Mohd Saad Qodriyah
    Drugs & Aging, 2022, 39 : 487 - 504
  • [25] Relationship Amongst Vitamin K Status, Vitamin K Antagonist Use and Osteoarthritis: A Review
    Chin, Kok-Yong
    Pang, Kok-Lun
    Wong, Sok Kuan
    Chew, Deborah Chia Hsin
    Qodriyah, Haji Mohd Saad
    DRUGS & AGING, 2022, 39 (07) : 487 - 504
  • [26] Urgent reversal of vitamin K antagonist therapy
    Vang, M. L.
    Hvas, A. M.
    Ravn, H. B.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2011, 55 (05) : 507 - 516
  • [27] Commentary on variability in vitamin K antagonist metabolism
    Smith, Dennis A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (01) : 1 - 2
  • [28] Haematoma expansion and vitamin K antagonist reversal
    Zemrak, Wesley R.
    Smith, Kathryn E.
    Gagnon, David J.
    Rolfe, Stephen S.
    Seder, David B.
    LANCET NEUROLOGY, 2016, 15 (11): : 1116 - 1117
  • [29] Switching from a vitamin K antagonist to a NOAC
    Senoo, Keitaro
    Lip, Gregory Y. H.
    LANCET HAEMATOLOGY, 2015, 2 (04): : E132 - E133
  • [30] Risk factors of vitamin K antagonist overcoagulation
    Marie, I.
    Leprince, P.
    Menard, J. -F.
    Tharasse, C.
    Levesque, H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (01) : 53 - 62
12345